Stock Events

Stock Events

BioXcel Therapeutics (BX20.F) Q4 2024 Earnings

14NovConfirmed

Q4 2024

-7.68

-6.74

-5.8

-4.86

Details

Expected EPS

-7.681500597099999

Actual EPS

-4.8622592

Surprise EPS

2.82

Surprise Percent

+36.7%

Description

BioXcel Therapeutics (BX20.F) has reported earnings of -4.8622592 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.